Cited by 84Renal and Vascular PathologiesBlood Pressure and Hypertension StudiesRenin-Angiotensin System Studies

Current Concepts in the Treatment of Renovascular Hypertension

Open access
Herrmann, Sandra M, Textor, Stephen C·2018·American Journal of Hypertension

Abstract

Renovascular disease (RVD) remains a major cause of secondary and treatment-resistant hypertension. Most cases are related either to fibromuscular or atherosclerotic lesions, but a variety of other causes including arterial dissection, stent occlusion, and embolic disease can produce the same syndrome. Recent studies emphasize the kidney’s tolerance to moderate flow reduction during antihypertensive drug therapy and the relative safety of medical therapy to control blood pressure. Several prospective trials in moderate RVD fail to identify major benefits from endovascular revascularization for moderate atherosclerotic disease. However, high-risk and progressive renovascular syndromes are recognized to be relatively refractory to medical therapy only and respond better to combining renal revascularization with ongoing medical therapy. Clinicians caring for complex hypertension should be familiar with pathogenic pathways, imaging techniques, and a rational approach to managing renovascular hypertension in the current era.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ajh/hpx154

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Loesch J. Ein Beitrag zur experimentellen Nephritis und zum arteriellen Hochdruck I. Die Veranderungen im Blutdruck II. Die Veranderungen in der Blutchemie. Zentralblatt fur Innere Medizin 1933; 7:144-169.
  2. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experi- mental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934; 59:347-379.
  3. Gloviczki ML, Glockner JF, Crane JA, McKusick MA, Misra S, Grande JP, Lerman LO, Textor SC. BOLD magnetic resonance imaging identi- fies cortical hypoxia in severe renovascular disease. Hypertension 2011; 58:1066-1072.
  4. Losito A, Selvi A, Parente B, Cao P. Beneficial effect of ACE inhibi- tion on survival of patients with renovascular hypertension. J Am Soc Nephrol 1997; 8:142A-143A.
  5. Ziakka S, Ursu M, Poulikakos D, Papadopoulos C, Karakasis F, Kaperonis N, Papagalanis N. Predictive factors and therapeutic approach of renovascular disease. Ren Fail 2008; 30:965-970.

Cited by

Sorted by citations

Authors
Herrmann, S. M., & Textor, S. C.
Affiliations
Mayo Clinic (US)
Corresponding author
Textor, Stephen C
Venue
American Journal of Hypertension
Published
2017-08-16
Volume
31
Issue
2
Pages
139-149
ISSN
  • 0895-7061 (ISSN-L)
  • 1941-7225
OpenAlex
W2750164047
Cited by
84
References
78
Citations by year
2026: 6 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 14 · 2021: 12 · 2020: 17 · 2019: 7 · 2018: 3 · 2017: 1
FWCI
1.40
Type
journal article
Language
en
Open access
Locations
  • American Journal of Hypertension (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1 RR024150)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK100081)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal and Vascular Pathologies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
renovascular hypertension, secondary hypertension, treatment-resistant hypertension, renal artery stenosis, fibromuscular dysplasia, atherosclerosis, renal revascularization, endovascular revascularization, antihypertensive therapy, renal blood flow, arterial dissection, stent occlusion, embolic disease
MeSH terms
Animals, Antihypertensive Agents, Blood Pressure, Humans, Hypertension, Renovascular, Renal Artery Obstruction, Risk Factors, Stents, Treatment Outcome, Endovascular Procedures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review